Company intelligence / Profile preview

ProFound Therapeutics

Cambridge, Massachusetts, United Statesprofoundtx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

ProFound has built an extensive database (“Atlas”) of tens of thousands of previously unannotated human proteins using its proprietary platform. It aims to leverage these discoveries to develop first-in-class medicines across multiple disease areas. The company’s most advanced public program involves foundational research for next-generation therapies for obesity in collaboration with Flagship Pioneering/Pfizer; no clinical results have been reported yet.

Therapeutic areas: OtherOncologyMetabolic Disorders
Modalities: Protein therapeutics (novel proteins from the expanded human proteome)Potentially others as platform expands (not explicitly listed)
Industry: Biotech

Partnerships

Flagship Pioneering/Pioneering MedicinesPfizer

Beyond the preview

Go deeper on ProFound Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProFound Therapeutics.

Explore the full profile